Register entry
KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 24
- Countries
- 0
Exclusivity
Patents and exclusivities
24| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8377880 | PARSABIVetelcalcetide | substance, product | Jul 2030 |
| 9278995 | PARSABIVetelcalcetide | substance | Jul 2030 |
| 9701712 | PARSABIVetelcalcetide | substance, product | Jul 2030 |
| 8999932 | PARSABIVetelcalcetide | substance, product | Feb 2031 |
| 10344765 | PARSABIVetelcalcetide | product | Jun 2034 |
| 11162500 | PARSABIVetelcalcetide | product | Jun 2034 |
| 11959486 | PARSABIVetelcalcetide | product | Jun 2034 |
| 9820938 | PARSABIVetelcalcetide | product | Jun 2034 |
Enquiry
Common questions
- Is KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC FDA approved?
- KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.